Challenges and Opportunities in the Evaluation of Nutraceuticals in Cardiovascular Diseases

por Sharma, Abhinav, Felker, G. Michael
Publicado 2021

Innovation in Diuretic Therapy: The Missing Ingredient for Treating Worsening Heart Failure Outside the Hospital?

por Greene, Stephen J., Felker, G. Michael
Publicado 2018

Role of Volume Redistribution in the Congestion of Heart Failure

por Fudim, Marat, Hernandez, Adrian F., Felker, G. Michael
Publicado 2017

Novel approach to classifying patients with pulmonary arterial hypertension using cluster analysis

por Parikh, Kishan S., Rao, Youlan, Ahmad, Tariq, Shen, Kai, Felker, G. Michael, Rajagopal, Sudarshan
Publicado 2017

Plasma metabolites associated with functional and clinical outcomes in heart failure with reduced ejection fraction with and without type 2 diabetes

por Lerman, Joseph B., Giamberardino, Stephanie N., Hernandez, Adrian F., Felker, G. Michael, Shah, Svati H., McGarrah, Robert W.
Publicado 2022

Vasodilators in the treatment of acute heart failure: what we know, what we don’t

por Metra, Marco, Teerlink, John R., Voors, Adriaan A., Felker, G. Michael, Milo-Cotter, Olga, Weatherley, Beth, Dittrich, Howard, Cotter, Gad
Publicado 2008

Mechanistic Efficacy of Sacubitril/Valsartan in Ischemic Versus Nonischemic Heart Failure

por Mohebi, Reza, Liu, Yuxi, Felker, G. Michael, Ward, Jonathan H., Piña, Ileana L., Butler, Javed, Solomon, Scott D., Januzzi, James L.
Publicado 2023

Best Practices for Prognostic Evaluation of a Patient With Transthyretin Amyloid Cardiomyopathy

por Feng, Kent Y., Loungani, Rahul S., Rao, Vishal N., Patel, Chetan B., Khouri, Michel G., Felker, G. Michael, DeVore, Adam D.
Publicado 2019

Relaxin, a pleiotropic vasodilator for the treatment of heart failure

por Teichman, Sam L., Unemori, Elaine, Dschietzig, Thomas, Conrad, Kirk, Voors, Adriaan A., Teerlink, John R., Felker, G. Michael, Metra, Marco, Cotter, Gad
Publicado 2008

Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction After a Recent Worsening Heart Failure Event

por Carnicelli, Anthony P., Clare, Robert, Hofmann, Paul, Chiswell, Karen, DeVore, Adam D., Vemulapalli, Sreekanth, Felker, G. Michael, Sarocco, Phil, Mentz, Robert J.
Publicado 2021

Importance of the ‘area under the curve’ from serial NT‐proBNP measurements during treatment with sacubitril/valsartan

por Mohebi, Reza, Liu, Yuxi, Butler, Javed, Felker, G. Michael, Ward, Jonathan H., Prescott, Margaret F., Piña, Ileana L., Solomon, Scott D., Januzzi, James L.
Publicado 2023

Machine Learning Methods Improve Prognostication, Identify Clinically Distinct Phenotypes, and Detect Heterogeneity in Response to Therapy in a Large Cohort of Heart Failure Patien...

por Ahmad, Tariq, Lund, Lars H., Rao, Pooja, Ghosh, Rohit, Warier, Prashant, Vaccaro, Benjamin, Dahlström, Ulf, O'Connor, Christopher M., Felker, G. Michael, Desai, Nihar R.
Publicado 2018

Association Between Sacubitril/Valsartan Initiation and Mitral Regurgitation Severity in Heart Failure With Reduced Ejection Fraction: The PROVE-HF Study

por Januzzi, James L., Omar, Alaa Mabrouk Salem, Liu, Yuxi, Murphy, Sean, Butler, Javed, Felker, G. Michael, Piña, Iliana L., Ward, Jonathan, Solomon, Scott, Contreras, Johanna
Publicado 2022

Clinical Implications of Cluster Analysis-Based Classification of Acute Decompensated Heart Failure and Correlation with Bedside Hemodynamic Profiles

por Ahmad, Tariq, Desai, Nihar, Wilson, Francis, Schulte, Phillip, Dunning, Allison, Jacoby, Daniel, Allen, Larry, Fiuzat, Mona, Rogers, Joseph, Felker, G. Michael, O’Connor, Christopher, Patel, Chetan B.
Publicado 2016

Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre-RELAX-AHF study

por Metra, Marco, Teerlink, John R., Felker, G. Michael, Greenberg, Barry H., Filippatos, Gerasimos, Ponikowski, Piotr, Teichman, Sam L., Unemori, Elaine, Voors, Adriaan A., Weatherley, Beth Davison, Cotter, Gad
Publicado 2010

Effects of Omecamtiv Mecarbil on Symptoms and Health-Related Quality of Life in Patients With Chronic Heart Failure: Results From the COSMIC-HF Study

por Felker, G. Michael, Solomon, Scott D., McMurray, John J.V., Cleland, John G.F., Abbasi, Siddique A., Malik, Fady I., Zhang, Hanze, Globe, Gary, Teerlink, John R.
Publicado 2020

Sex‐based differences in biomarkers, health status, and reverse cardiac remodelling in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan...

por Ibrahim, Nasrien E., Piña, Ileana L., Camacho, Alexander, Bapat, Devavrat, Felker, G. Michael, Maisel, Alan S., Butler, Javed, Prescott, Margaret F., Abbas, Cheryl A., Solomon, Scott D., Januzzi, James L.
Publicado 2020

Racial and Ethnic Differences in Biomarkers, Health Status, and Cardiac Remodeling in Patients With Heart Failure With Reduced Ejection Fraction Treated With Sacubitril/Valsartan

por Ibrahim, Nasrien E., Piña, Ileana L., Camacho, Alexander, Bapat, Devavrat, Felker, G. Michael, Maisel, Alan S., Butler, Javed, Prescott, Margaret F., Abbas, Cheryl A., Solomon, Scott D., Januzzi, James L.
Publicado 2020

Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF

por Felker, G. Michael, Butler, Javed, Ibrahim, Nasiren E., Piña, Ileana L., Maisel, Alan, Bapat, Devavrat, Camacho, Alexander, Ward, Jonathan H., Williamson, Kristin M., Solomon, Scott D., Januzzi, James L.
Publicado 2021

Heart Failure Across the Range of Mildly Reduced and Preserved Ejection Fraction in the United States

por Greene, Stephen J., Spertus, John A., Tang, Wenxi, Kang, Amiee, Zhong, Yue, Myers, Michael C., Shen, Sophie, Jiang, Jenny, Liu, Xuejun, Steffen, David R., Viola, Marta G., Felker, G. Michael
Publicado 2023